Pre-hospital Advanced Therapies for Control of Hemorrhage - Pelvis
NCT02855060 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 50
Last updated 2022-04-21
Summary
The purpose of this study is to determine whether the use of pelvic binders in the ambulance setting improves outcomes including mortality in patients with pelvic fractures.
Conditions
- Hemorrhage
- Pelvic Fracture
Interventions
- DEVICE
-
Pelvic Binder
Sponsors & Collaborators
-
Wake Forest University Health Sciences
lead OTHER
Principal Investigators
-
Joseph R Hsu, MD · Wake Forest University Health Sciences
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Max Age
- 64 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2016-07-31
- Primary Completion
- 2018-06-30
- Completion
- 2018-12-31
Countries
- United States
Study Locations
More Related Trials
-
California Prehospital and In Hospital Antifibrinolytic Therapy Via TXA
NCT03469947 ·Status: COMPLETED ·Phase: PHASE3
-
Effect of Remote Ischemic Conditioning on Trauma Patients With Hemorrhagic Shock
NCT02071290 ·Status: COMPLETED ·Phase: NA
-
Pre-hospital Anti-fibrinolytics for Traumatic Coagulopathy and Haemorrhage (The PATCH Study)
NCT02187120 ·Status: COMPLETED ·Phase: PHASE3
-
EmboCube Gelatin Embolization to Control Bleeding or Hemorrhaging
NCT05307783 ·Status: COMPLETED
-
Use of ROTEM Intraoperatively in Women With Placenta Accreta
NCT02729974 ·Status: COMPLETED ·Phase: NA
-
Comparative Use of Tranexamic Acid Intravenous and Topical Application in Intertrochanteric Fractures With PFNA
NCT04696224 ·Status: UNKNOWN ·Phase: NA
-
Bipolar Hemostatic Forceps Versus Standard Therapy in Acute Non-variceal Upper GI Bleeding
NCT05353062 ·Status: UNKNOWN ·Phase: NA
-
Hemostasis in Open Acetabulum and Pelvic Ring Surgery Using Tranexamic Acid
NCT02051686 ·Status: COMPLETED ·Phase: NA
-
The EVARREST® Pediatric Mild or Moderate Liver and Soft Tissue Bleeding Study
NCT03255174 ·Status: COMPLETED ·Phase: PHASE3
-
Impact of a Prehospital Identification of Trauma Patients in Need for Damage Control Resuscitation.
NCT03444077 ·Status: UNKNOWN ·Phase: NA
-
Transfusion of Red Blood Cells, Tranexamic Acid and Fibrinogen Concentrate for Severe Trauma Hemorrhage
NCT04149171 ·Status: COMPLETED ·Phase: PHASE3
-
Pilot Randomized Trial of Fibrinogen in Trauma Haemorrhage
NCT02344069 ·Status: COMPLETED ·Phase: PHASE2
-
Implementing Treatment Algorithms for the Correction of Trauma Induced Coagulopathy
NCT02593877 ·Status: COMPLETED ·Phase: PHASE2
-
Pre-hospital Administration of Fibrinogen in Trauma-Induced Coagulopathy
NCT06582420 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Blood Loss After Early TXA in Hip Fractures.
NCT04488367 ·Status: UNKNOWN ·Phase: EARLY_PHASE1
-
Pre-Hospital Use of Plasma for Traumatic Hemorrhage
NCT02303964 ·Status: WITHDRAWN ·Phase: PHASE2/PHASE3
-
Intraventricular Rt-PA in Patients With Intraventricular Hemorrhage
NCT00029315 ·Status: COMPLETED ·Phase: PHASE2
-
Prospective, Multicenter, Multidisciplinary, Controlled Clinical Investigation Evaluating the Safety and Efficacy of PerClot® Polysaccharide Hemostatic System
NCT02359994 ·Status: COMPLETED ·Phase: NA
-
Fibrinogen Concentrate (FGTW) in Trauma Patients, Presumed to Bleed (FI in TIC)
NCT01475344 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Patient Blood Management for Massive Obstetric Hemorrhage
NCT03784794 ·Status: COMPLETED ·Phase: NA
-
Effectiveness of the Use of the New Hemostatic Patch Hemopatch ® in Patients Undergoing Surgical Liver Resection
NCT02769754 ·Status: UNKNOWN ·Phase: PHASE3
-
Prehospital Transfusion Strategy in Bleeding Patients
NCT04879485 ·Status: COMPLETED ·Phase: NA
-
Does Early Administration of Tranexamic Acid Reduce Blood Loss and Perioperative Transfusion Requirement
NCT03182751 ·Status: COMPLETED ·Phase: PHASE2
-
Safety and Efficacy of PolyHeme(R) in Hemorrhagic Shock Following Traumatic Injuries Beginning in the Pre-Hospital Setting
NCT00076648 ·Status: UNKNOWN ·Phase: PHASE3
-
Study on Patient Blood Management in Haematological Patients
NCT03217370 ·Status: SUSPENDED ·Phase: NA